DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2

Table 1 Correlation between DUXAP8 expression and clinicopathologic characteristics of patients with PDAC

Characteristics	N	Percent (%)	DUXAP8 level		P
Characteristics	N	Percent (%)	Low	High	Chi squared test
Total cases	58	100	29	29
Gender					0.790
Male	34	58.6	16	18
Female	24	41.4	13	11
Age (years)					1.000
< 65	29	50.0	14	15
≥ 65	29	50.0	15	14
Tumor size					0.033
< 3 cm	25	43.1	17	8
≥ 3 cm	33	56.9	12	21
Differentiation					0.289
Well/moderate	25	43.1	15	10
Poor	33	56.9	14	19
TNM stage					0.034
I/II	27	46.6	18	9
III/IV	31	53.4	11	20
Lymph-node metastasis					0.065
Negative	30	51.7	19	11
Positive	28	48.3	10	18

ISSN: 2523-3548